ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,287, issued on May 13, was assigned to IMPLICIT BIOSCIENCE Ltd. (Queensland, Australia).
"CD14 antagonist antibodies for treating neurodegenerative diseases" was invented by Garry Llewellyn Redlich (East Brisbane, Australia).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates generally to agents and methods for treating the development or progression of a neurodegenerative disease. In particular, the present invention relates to CD14 antagonists for use in treating the development or progression of a neurodegenerative disease, including Motor Neurone Disease (MND) and Dementia disease or associated symptoms. The present invention fu...